Business · 20/02/2001

Temporary Delay of Postmarketing Study Rule Effective Date

The rule requiring postmarketing studies for approved human drugs and licensed biological products has been temporarily delayed by 60 days due to a review plan initiated by the Assistant to the President and Chief of Staff in 2001.